Developer docs
API playgroundTry for free, no card

Search company profiles

Rockland Immunochemicals

Full company profile

uuid0009pv9

Namestring
Rockland Immunochemicals
Legal namestring
Rockland Immunochemicals, Inc.
Websiteurl
rockland.com
Company typeenum
Private
Founded yearint
1962
Descriptiontext

Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 and headquartered in Limerick, Pennsylvania, that develops, manufactures, and distributes antibody-based reagents, kits, blood products, proteins, and supporting consumables, alongside a full suite of contract research and custom manufacturing services. Its catalog spans primary and secondary antibodies, blood products, proteins and peptides, cell lines and lysates, supporting reagents, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible secondary antibodies and kits), and AccuSignal™ (over 800 ready-to-use ELISA kits, including a recently launched E. coli HCP kit). The company's services arm covers the full discovery-to-release pipeline: custom monoclonal, polyclonal, anti-oligonucleotide and anti-idiotypic antibody production; custom recombinant antibodies; protein and antibody characterization using bio-layer interferometry; antibody modification; ADA, cell-based and immunoassay development; cell banking and virus particle manufacturing; and analytical services for gene therapy, RNA therapeutics, and host cell protein impurity detection.

The business operates a hybrid revenue model combining unit-priced catalog and bulk reagent sales (e.g., individual catalog items ranging from approximately $38 to over $1,300 per unit, with bulk supply in milligrams-to-hundreds-of-grams volumes for IVD, pharma, and biotech manufacturers) and quote-based custom services typically structured as multi-year contracts. Customers are organized across four verticals: Biopharma, Diagnostics, Emerging Therapeutics (cell, gene, and RNA oligonucleotide therapies), and AgBio. Go-to-market is sales-led, executed through the rockland.com e-commerce storefront, a worldwide distributor network, a dedicated bulk-order enterprise channel, and the 2022-acquired antibodies-online GmbH European digital marketplace, supported by a content-driven marketing strategy including a 188-resource scientific library, email, social media, and webinars. US-based R&D and manufacturing at the Limerick facility, combined with 60+ years of operating history and a portfolio of registered trademarks, form the operational and reputational backbone of the franchise.

Short descriptiontext

Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 that develops, manufactures, and sells antibody-based reagents, kits, and custom antibody services to biopharma, diagnostics, emerging therapeutics, and AgBio customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLimerick, United States
HQ citystring
Limerick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antibody reagents, custom antibody production, life science reagents, immunoassay development, ELISA kits
Industry4 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAB
Immunoassay Diagnostics (ELISA, chemiluminescence, serology)
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Science Reagents (Antibodies and Immunoassay Kits)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Catalog Antibodies and Reagents
TypeOne Time License
Description

Sale of primary antibodies, secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits, and specialty panels through e-commerce platform with standard product pricing.

rockland.com
2Custom Antibody Production Services
TypeProfessional Services
Description

Custom antibody generation including monoclonal, polyclonal, anti-oligonucleotide, and anti-idiotypic antibodies. Services include the entire process from injection to validation and shipment.

rockland.com
3Protein and Antibody Characterization Services
TypeProfessional Services
Description

Bio-layer interferometry services, qualification and validation, and stability study services for client samples.

rockland.com
4Assay Development Services
TypeProfessional Services
Description

ADA assay development, cell-based assay development, and immunoassay development services for therapeutic development programs.

rockland.com
5Cell Culture and Gene Therapy Services
TypeProfessional Services
Description

Cell banking, storage, virus particle manufacturing, and analytical services for gene therapy programs.

rockland.com
6Bulk Orders
TypeOne Time License
Description

Large-scale procurement of catalog items from milligrams to hundreds of grams for pharmaceutical, biotech, and IVD manufacturers.

rockland.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details3 tiers
1Catalog antibodies and reagents with publicly listed prices
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products like TRAF2 Antibody at $589.00 per 100 µg, TNF alpha Antibodies ranging from $125.00 to $1,302.00 depending on size. Polymount Mounting Media at $38.00 per 15 mL.

rockland.com
2Bulk orders for pharmaceutical and biotech manufacturers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Volume pricing available from milligrams to hundreds of grams for industrial customers including IVD, pharmaceutical, and biotech companies.

rockland.com
3Custom services quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Custom antibody production, characterization services, assay development, and other service offerings are provided on a quote basis tailored to project requirements.

rockland.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1ModDetect™
Description

Panel of specialty reagents designed to detect nucleic acid modifications independent of sequence, format, or location.

rockland.com
+2 more records
Core offering1 text field

Rockland Immunochemicals manufactures and sells a catalog of primary and secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits (including over 800 AccuSignal ELISA kits) and branded reagent lines ModDetect and TrueBlot, all produced at its US-based facilities. It also provides full-service custom antibody production (monoclonal, polyclonal, recombinant, anti-oligonucleotide, anti-idiotypic), antibody and protein characterization (bio-layer interferometry, qualification, stability), assay development (ADA, cell-based, immunoassay), antibody modification (conjugation, fragmentation, purification), cell culture and virus particle manufacturing, protein expression and purification, and analytical services supporting gene therapy and RNA therapeutics programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 800 AccuSignal ELISA kits available for common research targets
+1 more record
Product overview1 text field

Rockland Immunochemicals is a life science reagents company founded in 1962, offering a comprehensive portfolio of antibodies, blood products, proteins, peptides, reagents, cell lines, and kits alongside a full range of contract research and manufacturing services. The core product portfolio is organized around Primary Antibodies (monoclonal, polyclonal, recombinant, epitope-tag, RFP & GFP, loading control), Secondary Antibodies (conjugated, unconjugated, pre-adsorbed, Fab fragments), Blood Products (species-specific RBCs, serum, plasma, complement), Proteins & Peptides, Supporting Reagents, Cell Lines & Lysates, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible detection reagents), and AccuSignal™ (800+ ELISA kits). The services arm encompasses the full discovery-to-release pipeline: Custom Antibody Production, Custom Recombinant Antibodies, Protein & Antibody Characterization (BLI, validation, stability), Antibody Modification (conjugation, fragmentation, purification), Assay Development (ADA, cell-based, immunoassay), Cell Culture Services, Protein Expression & Purification, Analytical Tools for RNA Therapeutics, Analytical Tools for Impurity Detection (HCP), and Analytical Services for Gene Therapy. Rockland also offers industry-specific solutions for AgBio, Biopharma, Diagnostics, and Emerging Therapeutics markets, with US-based manufacturing for reproducibility and minimal lot-to-lot variability.

Product and service19 records
1Primary Antibodies
CategoryAntibodies
2Secondary Antibodies
CategoryAntibodies
3Blood Products
CategoryBiological Reagents
4Proteins and Peptides
CategoryBiological Reagents
5Supporting Reagents
CategoryLaboratory Reagents
6Cell Lines and Lysates
CategoryBiological Reagents
7ModDetect Antibody Panels
CategorySpecialty Antibody Panels
8TrueBlot IP and Western Blot Reagents
CategorySpecialty Antibody Reagents
9AccuSignal ELISA Kits
CategoryAssay Kits
10Custom Antibody Production
CategoryCustom Antibody Services
11Custom Recombinant Antibodies (rAbs)
CategoryCustom Antibody Services
12Protein and Antibody Characterization
CategoryAnalytical Services
13Antibody Modification Services
CategoryCustom Antibody Services
14Assay Development Services
CategoryAnalytical Services
15Cell Culture Services
CategoryBioprocessing Services
16Protein Expression and Purification
CategoryBioprocessing Services
17Analytical Tools for RNA Therapeutics
CategoryAnalytical Services
18Analytical Tools for Impurity Detection
CategoryAnalytical Services
19Analytical Services for Gene Therapy
CategoryAnalytical Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-02-10
Description

Rockland acquired antibodies-online GmbH, a European online antibody distributor. This acquisition expanded Rockland's digital commerce presence and distribution capabilities in the European market.

2Jefferson Institute For Bioprocessing (JIB)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Rockland partners with JIB, which offers early phase pre-clinical process development, product and technology development and evaluation, analytical, and quality control services. This collaboration expands Rockland's offering in bioprocess control strategies for cell, gene, and RNA therapies.

rockland.com
Strategic tierMinorTypeOthers
Description

Listed as a partner on Rockland's website, indicating a collaborative relationship in the life sciences sector.

Strategic tierMinorTypeOthers
Description

Listed as a partner on Rockland's website, providing publication tracking and analytics services for scientific literature.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GenScript operates a large custom antibody and recombinant antibody/protein services business alongside a catalog reagent offering, directly mirroring Rockland's combined custom-services + catalog model for the biopharma and academic markets.

TypeDirect peer
Description

Abcam (now part of Danaher/Cytiva) is one of the largest research-grade antibody manufacturers globally with a deep catalog across primary and secondary antibodies, ELISA kits, and supporting reagents. It directly competes with Rockland's catalog and bulk-order business across academia, biopharma, and IVD customers.

TypeEmerging player
Description

Proteintech has rapidly scaled a direct-to-researcher antibody catalog with a focus on validated reagents, competing most directly with Rockland's primary antibody offering and increasingly with its supporting reagent/ELISA categories.

TypeDirect peer
Description

Cell Signaling Technology (CST) manufactures and sells highly validated antibodies, ELISA kits, and supporting reagents — directly overlapping Rockland's core catalog and biopharma analytical reagents portfolio, particularly in Western blot/immunoassay applications.

TypeEmerging player
Description

Sino Biological manufactures recombinant proteins, antibodies, and ELISA kits with a global catalog that increasingly competes with Rockland's protein/peptide, antibody, and bulk-order lines among biopharma and IVD customers.

TypeBroad incumbent
Description

Bio-Rad is a diversified life sciences tools incumbent whose life science research segment (including antibody reagents, ELISA kits, and Western blot products) directly competes with Rockland across academic, biopharma, and diagnostics customers.

TypeBroad incumbent
Description

Bio-Techne owns the Novus Biologicals brand — one of the largest antibody catalog competitors — and also offers ELISA kits and proteins, broadly overlapping Rockland's catalog portfolio across antibody specificity categories and validated ELISA offerings.

TypeDirect peer
Description

Jackson ImmunoResearch is a specialist manufacturer of secondary antibodies and conjugation reagents, directly comparable to Rockland's secondary antibodies, conjugated formats, and Fab fragment offerings.

TypeBroad incumbent
Description

Thermo Fisher's Life Sciences Solutions segment encompasses the Invitrogen, Pierce, and Thermo Scientific antibody/reagent brands. It serves as the dominant broad incumbent in reagents, ELISA kits, and supporting consumables that compete across Rockland's full catalog.

10Santa Cruz Biotechnology
TypeDirect peer
Description

Santa Cruz Biotechnology is a long-established direct competitor in research antibodies and supporting reagents, with a broad primary/secondary antibody catalog that overlaps heavily with Rockland's pricing-tier competing SKUs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rockland Immunochemicals

Life Science Reagents (Antibodies and Immunoassay Kits)rockland.com

Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 that develops, manufactures, and sells antibody-based reagents, kits, and custom antibody services to biopharma, diagnostics, emerging therapeutics, and AgBio customers globally.

What Rockland Immunochemicals does

Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 and headquartered in Limerick, Pennsylvania, that develops, manufactures, and distributes antibody-based reagents, kits, blood products, proteins, and supporting consumables, alongside a full suite of contract research and custom manufacturing services. Its catalog spans primary and secondary antibodies, blood products, proteins and peptides, cell lines and lysates, supporting reagents, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible secondary antibodies and kits), and AccuSignal™ (over 800 ready-to-use ELISA kits, including a recently launched E. coli HCP kit). The company's services arm covers the full discovery-to-release pipeline: custom monoclonal, polyclonal, anti-oligonucleotide and anti-idiotypic antibody production; custom recombinant antibodies; protein and antibody characterization using bio-layer interferometry; antibody modification; ADA, cell-based and immunoassay development; cell banking and virus particle manufacturing; and analytical services for gene therapy, RNA therapeutics, and host cell protein impurity detection.

The business operates a hybrid revenue model combining unit-priced catalog and bulk reagent sales (e.g., individual catalog items ranging from approximately $38 to over $1,300 per unit, with bulk supply in milligrams-to-hundreds-of-grams volumes for IVD, pharma, and biotech manufacturers) and quote-based custom services typically structured as multi-year contracts. Customers are organized across four verticals: Biopharma, Diagnostics, Emerging Therapeutics (cell, gene, and RNA oligonucleotide therapies), and AgBio. Go-to-market is sales-led, executed through the rockland.com e-commerce storefront, a worldwide distributor network, a dedicated bulk-order enterprise channel, and the 2022-acquired antibodies-online GmbH European digital marketplace, supported by a content-driven marketing strategy including a 188-resource scientific library, email, social media, and webinars. US-based R&D and manufacturing at the Limerick facility, combined with 60+ years of operating history and a portfolio of registered trademarks, form the operational and reputational backbone of the franchise.

Rockland Immunochemicals firmographics

Firmographics
Name
Rockland Immunochemicals
Legal name
Rockland Immunochemicals, Inc.
Website
https://rockland.com
Company type
Private
Founded year
1962
Operating status
Operating
Headcount range
101–250 employees
Short description
Rockland Immunochemicals is a privately-held US biotechnology company founded in 1962 that develops, manufactures, and sells antibody-based reagents, kits, and custom antibody services to biopharma, diagnostics, emerging therapeutics, and AgBio customers globally.
Ownership category
akta.pro rank

Rockland Immunochemicals industry classification

Industry
Product category
Life Science Reagents (Antibodies and Immunoassay Kits)
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAB
Immunoassay Diagnostics (ELISA, chemiluminescence, serology)
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Antibody reagents
  • Custom antibody production
  • Life science reagents
  • Immunoassay development
  • ELISA kits

Where Rockland Immunochemicals is headquartered

Location

Headquarters

HQ city
Limerick
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rockland Immunochemicals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Catalog Antibodies and Reagents: Sale of primary antibodies, secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits, and specialty panels through e-commerce platform with standard product pricing.
  2. Custom Antibody Production Services: Custom antibody generation including monoclonal, polyclonal, anti-oligonucleotide, and anti-idiotypic antibodies. Services include the entire process from injection to validation and shipment.
  3. Protein and Antibody Characterization Services: Bio-layer interferometry services, qualification and validation, and stability study services for client samples.
  4. Assay Development Services: ADA assay development, cell-based assay development, and immunoassay development services for therapeutic development programs.
  5. Cell Culture and Gene Therapy Services: Cell banking, storage, virus particle manufacturing, and analytical services for gene therapy programs.
  6. Bulk Orders: Large-scale procurement of catalog items from milligrams to hundreds of grams for pharmaceutical, biotech, and IVD manufacturers.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog antibodies and reagents with publicly listed prices
Unit PricingPay-as-you-goBulk orders for pharmaceutical and biotech manufacturers
OtherMulti-year contractCustom services quote-based

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Rockland Immunochemicals product offering

Product offering

Core offering

Rockland Immunochemicals manufactures and sells a catalog of primary and secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits (including over 800 AccuSignal ELISA kits) and branded reagent lines ModDetect and TrueBlot, all produced at its US-based facilities. It also provides full-service custom antibody production (monoclonal, polyclonal, recombinant, anti-oligonucleotide, anti-idiotypic), antibody and protein characterization (bio-layer interferometry, qualification, stability), assay development (ADA, cell-based, immunoassay), antibody modification (conjugation, fragmentation, purification), cell culture and virus particle manufacturing, protein expression and purification, and analytical services supporting gene therapy and RNA therapeutics programs.

Product overview

Rockland Immunochemicals is a life science reagents company founded in 1962, offering a comprehensive portfolio of antibodies, blood products, proteins, peptides, reagents, cell lines, and kits alongside a full range of contract research and manufacturing services. The core product portfolio is organized around Primary Antibodies (monoclonal, polyclonal, recombinant, epitope-tag, RFP & GFP, loading control), Secondary Antibodies (conjugated, unconjugated, pre-adsorbed, Fab fragments), Blood Products (species-specific RBCs, serum, plasma, complement), Proteins & Peptides, Supporting Reagents, Cell Lines & Lysates, and branded product lines including ModDetect™ (oligonucleotide modification detection panels), TrueBlot® (IP-compatible detection reagents), and AccuSignal™ (800+ ELISA kits). The services arm encompasses the full discovery-to-release pipeline: Custom Antibody Production, Custom Recombinant Antibodies, Protein & Antibody Characterization (BLI, validation, stability), Antibody Modification (conjugation, fragmentation, purification), Assay Development (ADA, cell-based, immunoassay), Cell Culture Services, Protein Expression & Purification, Analytical Tools for RNA Therapeutics, Analytical Tools for Impurity Detection (HCP), and Analytical Services for Gene Therapy. Rockland also offers industry-specific solutions for AgBio, Biopharma, Diagnostics, and Emerging Therapeutics markets, with US-based manufacturing for reproducibility and minimal lot-to-lot variability.

Differentiator

Problem solved

Functional benefit

Brands

  • ModDetect™: Panel of specialty reagents designed to detect nucleic acid modifications independent of sequence, format, or location.
  • TrueBlot®
  • AccuSignal™

Products and services

  • Primary Antibodies
  • Secondary Antibodies
  • Blood Products
  • Proteins and Peptides
  • Supporting Reagents
  • Cell Lines and Lysates
  • ModDetect Antibody Panels
  • TrueBlot IP and Western Blot Reagents
  • AccuSignal ELISA Kits
  • Custom Antibody Production
  • Custom Recombinant Antibodies (rAbs)
  • Protein and Antibody Characterization
  • Antibody Modification Services
  • Assay Development Services
  • Cell Culture Services
  • Protein Expression and Purification
  • Analytical Tools for RNA Therapeutics
  • Analytical Tools for Impurity Detection
  • Analytical Services for Gene Therapy

Quantifiable outcome

  • Over 800 AccuSignal ELISA kits available for common research targets
  • +1 more outcomes

Companies that use Rockland Immunochemicals

Customer profile

Segments4 records

Ideal customer profiles5 records

Rockland Immunochemicals technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Rockland Immunochemicals partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered major, core and minor.

  • antibodies-online GmbHmajorChannel Partner/ Reseller/ Distributor · 10 February 2022Rockland acquired antibodies-online GmbH, a European online antibody distributor. This acquisition expanded Rockland's digital commerce presence and distribution capabilities in the European market.
  • Jefferson Institute For Bioprocessing (JIB)coreStrategic or Co-development PartnerRockland partners with JIB, which offers early phase pre-clinical process development, product and technology development and evaluation, analytical, and quality control services. This collaboration expands Rockland's offering in bioprocess control strategies for cell, gene, and RNA therapies.
  • Abzyme TherapeuticsminorOthersListed as a partner on Rockland's website, indicating a collaborative relationship in the life sciences sector.
  • PubGrademinorOthersListed as a partner on Rockland's website, providing publication tracking and analytics services for scientific literature.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Rockland Immunochemicals competitors and assessment

Company assessment

Direct peers

  • GenScript: GenScript operates a large custom antibody and recombinant antibody/protein services business alongside a catalog reagent offering, directly mirroring Rockland's combined custom-services + catalog model for the biopharma and academic markets.
  • Abcam: Abcam (now part of Danaher/Cytiva) is one of the largest research-grade antibody manufacturers globally with a deep catalog across primary and secondary antibodies, ELISA kits, and supporting reagents. It directly competes with Rockland's catalog and bulk-order business across academia, biopharma, and IVD customers.
  • Cell Signaling Technology: Cell Signaling Technology (CST) manufactures and sells highly validated antibodies, ELISA kits, and supporting reagents — directly overlapping Rockland's core catalog and biopharma analytical reagents portfolio, particularly in Western blot/immunoassay applications.
  • Jackson ImmunoResearch: Jackson ImmunoResearch is a specialist manufacturer of secondary antibodies and conjugation reagents, directly comparable to Rockland's secondary antibodies, conjugated formats, and Fab fragment offerings.
  • Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established direct competitor in research antibodies and supporting reagents, with a broad primary/secondary antibody catalog that overlaps heavily with Rockland's pricing-tier competing SKUs.

Emerging players

  • Proteintech: Proteintech has rapidly scaled a direct-to-researcher antibody catalog with a focus on validated reagents, competing most directly with Rockland's primary antibody offering and increasingly with its supporting reagent/ELISA categories.
  • Sino Biological: Sino Biological manufactures recombinant proteins, antibodies, and ELISA kits with a global catalog that increasingly competes with Rockland's protein/peptide, antibody, and bulk-order lines among biopharma and IVD customers.

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad is a diversified life sciences tools incumbent whose life science research segment (including antibody reagents, ELISA kits, and Western blot products) directly competes with Rockland across academic, biopharma, and diagnostics customers.
  • Bio-Techne (Novus Biologicals): Bio-Techne owns the Novus Biologicals brand — one of the largest antibody catalog competitors — and also offers ELISA kits and proteins, broadly overlapping Rockland's catalog portfolio across antibody specificity categories and validated ELISA offerings.
  • Thermo Fisher Scientific (Life Sciences Solutions): Thermo Fisher's Life Sciences Solutions segment encompasses the Invitrogen, Pierce, and Thermo Scientific antibody/reagent brands. It serves as the dominant broad incumbent in reagents, ELISA kits, and supporting consumables that compete across Rockland's full catalog.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Rockland Immunochemicals social profiles

Digital presence

Rockland Immunochemicals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rockland Immunochemicals leadership team

Management profile

Number of profiles

Profiles2 records

Rockland Immunochemicals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Rockland Immunochemicals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rockland Immunochemicals M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rockland Immunochemicals

What does Rockland Immunochemicals do?

Rockland Immunochemicals manufactures and sells a catalog of primary and secondary antibodies, blood products, proteins and peptides, supporting reagents, cell lines and lysates, kits (including over 800 AccuSignal ELISA kits) and branded reagent lines ModDetect and TrueBlot, all produced at its US-based facilities. It also provides full-service custom antibody production (monoclonal, polyclonal, recombinant, anti-oligonucleotide, anti-idiotypic), antibody and protein characterization (bio-layer interferometry, qualification, stability), assay development (ADA, cell-based, immunoassay), antibody modification (conjugation, fragmentation, purification), cell culture and virus particle manufacturing, protein expression and purification, and analytical services supporting gene therapy and RNA therapeutics programs.

Is Rockland Immunochemicals a public or private company?

Rockland Immunochemicals is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rockland Immunochemicals founded?

Rockland Immunochemicals was founded in 1962. It employs 101 to 250 people.

Where is Rockland Immunochemicals based?

Rockland Immunochemicals is headquartered in Limerick, United States, in the North America region.

How does Rockland Immunochemicals make money?

Six revenue lines are on record. Catalog Antibodies and Reagents are the primary driver. The others are custom Antibody Production Services, protein and Antibody Characterization Services, assay Development Services, cell Culture and Gene Therapy Services and bulk Orders.

Who are Rockland Immunochemicals's main competitors?

Direct peers on record are GenScript, Abcam, Cell Signaling Technology, Jackson ImmunoResearch and Santa Cruz Biotechnology. Emerging players are Proteintech and Sino Biological. Broad incumbents are Bio-Rad Laboratories, Bio-Techne (Novus Biologicals) and Thermo Fisher Scientific (Life Sciences Solutions).

Does Rockland Immunochemicals have an API?

No public API is recorded for Rockland Immunochemicals.

What industry is Rockland Immunochemicals in?

Rockland Immunochemicals's product category is Life Science Reagents (Antibodies and Immunoassay Kits). Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireEvoworks Bio Selected for BARDA-Backed VANGUARD Program to Demonstrate Rapid, Scalable Production of Critical BiologicsEvoworks Bio was selected for a BARDA-backed VANGUARD program to demonstrate rapid, scalable production of critical biologics. The 6-month project, with Kemp Proteins and Rockland Immunochemical, aims to cut quality-scale-up costs by 75% and validate antibodies on the EvoNode platform.PR NewswireAvoid Post-FACS Sorting Delays: Choosing the Best Single B Cell Workflow for Antibody Discovery, Upcoming Webinar Hosted by XtalksXtalks is hosting a free webinar on June 11-12, 2026, featuring Alain Agnememel from Rockland Immunochemicals, to present a decision framework for selecting single B-cell post-sort workflows in antibody discovery programs. The webinar will compare culture-based and recombinant expression approaches through case studies, addressing tradeoffs in throughput, timeline, and sequence recovery rates. This is an educational webinar announcement for life science professionals seeking guidance on optimizing FACS-guided single B-cell sorting workflows.ContractpharmaHigh-Throughput Antibody Screening to Support Rapid Therapeutic and Vaccine DevelopmentThis application note describes a high-throughput screening methodology for monoclonal antibodies targeting the H5N1 avian influenza strain (clade 2.3.4.4b), utilizing Rockland Immunochemicals' antibodies and Sartorius AG's Octet RH96 platform for label-free bio layer interferometry. The study integrates automated workflows through the Biosero GoSimple work cell to enable high-throughput screening and real-time assessment of antibody libraries. The methodology aims to accelerate antibody discovery and support the development of therapeutics and vaccines against emerging infectious pathogens.PR NewswireRockland Launches Novel Analytical Tools to Assess Drug Delivery: Revolutionizing Oligonucleotide Therapeutic DevelopmentRockland Immunochemicals has launched the ModDetect Phosphorothioate (PS) Panel, the first and only ready-to-use immunoassay-based reagent panel that can detect phosphorothioate modifications independent of nucleic acid composition, structure, or platform, designed to replace traditional in situ hybridization assays for oligonucleotide drug development. The panel consists of five reagents reactive specifically to phosphorothioate chemical modifications commonly designed into oligonucleotide therapeutics and can be used in ELISA, immunofluorescence, and immunohistochemistry applications. Rockland states this solution can save 9-12 months in drug development timelines by eliminating the need for unique probe design and accelerating candidate triage for ASO, siRNA, and mRNA therapeutic candidates.PR NewswireGlobal Research Antibodies and Reagents Market Report 2023: Major Players Include Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann La-Roche, Merck, PerkinElmer and LonzaResearchAndMarkets.com published its 2023 global market report on research antibodies and reagents, valued at $12.40 billion in 2021 and projected to grow to $16.90 billion by 2026 at a CAGR of 6.4%, driven by increasing investment in medical and health R&D. The report identifies reproducibility issues in antibodies and reagents, causing approximately $10 billion in annual preclinical research waste, as a key restraint on market growth. In February 2022, US-based Rockland Immunochemicals acquired Germany-based Antibodies-Online GmbH to enhance its antibody development capabilities and expand its e-commerce presence.YahooGlobal Immunochemicals IndustryThe global immunochemicals market is projected to grow from $3.7 billion in 2020 to $5.3 billion by 2027, a 5.3% CAGR. The U.S. market is estimated at $1.1 billion, while China is forecast to reach $929.7 million by 2027. Custom antibodies are expected to see a revised 6.9% CAGR.